Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (4): 563-568    DOI: 10.31083/j.ejgo.2020.04.4976
Original Research Previous articles | Next articles
Survival outcomes of sex cord-stromal tumors of the ovary
Krittiya Somaketarin1, Charuwan Tantipalakorn1, *(), Kittipat Charoenkwan1, Prapaporn Suprasert1, Jatupol Srisomboon1
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
Download:  PDF(289KB)  ( 241 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To evaluate the role of retroperitoneal lymphadenectomy and the survival outcomes of malignant ovarian sex cord-stromal tumors (SCSTs). Materials and Methods: Patients with malignant SCSTs of the ovary who underwent surgery between January 2005 and March 2017 were retrospectively reviewed. The authors analyzed stage, histology, clinical presentation, type of surgery, the role of lymphadenectomy, five-year disease-free survival, and five-year overall survival. Results: Fifty-four patients with malignant SCSTs of the ovary were identified in this study. Retroperitoneal lymph node dissection was performed in 30 (55.6%) patients. No lymph node metastasis was detected. At the median follow-up time of 35 months, the five-year disease-free survival and the five-year overall survival was 88.7% and 92.4%, respectively. Conclusion: The survival outcomes of women with ovarian sex cord-stromal malignancies are favorable. No lymph node metastasis is detected in this study. Retroperitoneal lymphadenectomy may be omitted in a surgical staging procedure for these patients.
Key words:  Ovarian sex cord-stromal tumor      Survival outcomes      Chemotherapy     
Submitted:  07 September 2018      Accepted:  22 November 2018      Published:  15 August 2020     
Fund: 
Faculty of Medicine, Chiang Mai University
National Research University Project under the Thailand Office of the Higher Education Commission
*Corresponding Author(s):  CHARUWAN TANTIPALAKORN     E-mail:  nokctantipa@gmail.com

Cite this article: 

Krittiya Somaketarin, Charuwan Tantipalakorn, Kittipat Charoenkwan, Prapaporn Suprasert, Jatupol Srisomboon. Survival outcomes of sex cord-stromal tumors of the ovary. European Journal of Gynaecological Oncology, 2020, 41(4): 563-568.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.04.4976     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I4/563

[1] Joseph J. Noh, Sir-Yeon Hong, Byeong-gie Kim. Malignant perivascular epithelioid cell tumor (PEComa) of uterus: A case report with literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 495-499.
[2] Sigit Purbadi, Gregorius Tanamas, Lisa Novianti. Advanced stage ovarian cancer survival in Jakarta[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 587-590.
[3] T. Shoji, E. Takatori, M. Kagabu, M. Futagami, Y. Yokoyama, H. Tokunaga, N. Yaegashi, T. Ohta, T. Watanabe, T Sugiyama. Relationship between usefulness of irinotecan and pegylated liposomal doxorubicin therapy and the UGT1A1 genotype in patients with recurrent ovarian cancer (TGCU 104 study)[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 380-385.
[4] H. Ishibashi, M. Miyamoto, T. Aoyama, H. Soyama, H. Matsuura, H. Iwahashi, M. Takano, K. Furuya. The effect of six scheduled cycles of neoadjuvant chemotherapy on prognosis in advanced ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 386-390.
[5] Chenchen Zhu, Hanyuan Liu, Zhen Shen, Yanhu Xie, Tianjiao Zhang, Björn Nashan, Dabao Wu, Ying Zhou. Treatment and survival outcomes from epithelial ovarian cancer in women aged 65 years or older[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 415-421.
[6] X.F. Xu, Q. Li, A.Y. Dai, H.J. Zhou, J.X. Ling. Neoadjuvant chemotherapy followed by radical surgery for Stage IB2 cervical cancer in pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 489-491.
[7] A. Antar, H. AlJawad, A. AlMuslim, N. El-Majzoub. Isolated late recurrence of epithelial ovarian cancer in cervical lymph nodes[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1067-1069.
[8] Yangyang Shi, Yongyun Shi, Dabao Wu. A case of placental site trophoblastic tumor and a retrospective analysis[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1096-1099.
[9] S. Dierckxsens, B. Geerinckx, M.T. Huizing, W.A.A. Tjalma. A review regarding the feasibility and accuracy of a sentinel lymph node biopsy after neo-adjuvant chemotherapy for breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 714-721.
[10] S. Cierniak, R. Koktysz, M. Jesiotr, A. Gąsowska-Bodnar, L. Bodnar. Expression of the PI3K/AKT/mTOR pathway as a prognostic factor in patients with advanced high grade serous ovarian carcinoma treated with neoadjuvant chemotherapy[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 744-751.
[11] S. Rahatli, H. Akilli, N. Haberal, O. Altundag, A. Haberal, A. Ayhan. Surgical management and outcomes of metastatic tumors to the ovaries[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 820-824.
[12] X. Xu, L. Zheng, B. Xue, M. Yao, Y. Xu. Primary Burkitt lymphoma presenting as ovarian tumor rupture: a case report and literature review[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 862-866.
[13] S. Furukawa, K. Hasegawa, Y. Nozawa, Y. Endo, M. Takata, F. Yoshida-Saito, S. Nakamura, R. Yamauchi. A rare case of primary ovarian leiomyosarcoma[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 870-874.
[14] F. El-Sharkawy, M. Sittig, C. Nieroda, A. Sardi. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent mucinous cystadenoma of the ovary[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 543-546.
[15] J.J. Noh, H. Jung, C.H. Choi. Mesonephric adenocarcinoma treated with paclitaxel-carboplatin adjuvant chemotherapy: a case report[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 679-683.
No Suggested Reading articles found!